![Mahindra Lifespaces appoints Amit Sinha](https://www.businessgujaratnews.com/wp-content/uploads/2021/09/mahindra-lifespace.jpg)
Mahindra Lifespaces appoints Amit Sinha as MD & CEO designate.
The Board of Mahindra Lifespace Developers Limited (MLDL) today announced Amit Kumar Sinha as the MD & CEO designate for MLDL. Amit will take over as MD & CEO from 23rd May 2023.
Amit joined Mahindra Group on 1st November 2020 as President – Group Strategy. He became a member of Group Executive Board from 1st April 2021. Over the past 2+ years, Amit led several high-impact projects covering growth, transformation, and capital allocation across Group companies. Amit is on the Board of Mahindra Finance, Mahindra Logistics, Mahindra Susten, Mahindra First Choice, Mahindra Rural Housing Finance and Fifth Gear Ventures.
Prior to joining the Mahindra Group, Amit was a Senior Partner and Director with Bain & Company. Over 18 years at Bain across US and India, he managed large-scale strategy, organization, and performance improvement projects covering numerous industries including infrastructure, real-estate, construction, energy, and technology.
Amit holds dual MBA from The Wharton School, University of Pennsylvania, specializing in Finance and Strategy, where he received coveted Palmer scholar award and Siebel scholarship for academic performance. He also holds a Bachelor of Engineering (Electrical and Electronics) from the Birla Institute of Technology, Ranchi. Amit is also an Ananta Aspen Fellow as part of their India leadership fellowship program.
The Mahindra Group strongly believes in the future growth potential of MLDL and is fully committed to scaling it to the next level. Amit brings a unique combination of leadership experiences, value creation skills, customer-first approach, people centricity and ESG commitments, which aligns well with the Mahindra Group’s Rise philosophy. We look forward to MLDL’s next phase of growth under Amit’s leadership.
Amit’s appointment is consequent to Arvind Subramanian’s decision to resign from MLDL with effect from 22nd May 2023, for personal reasons.